These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

827 related items for PubMed ID: 14677084

  • 1. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

  • 2. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Müller-Oerlinghausen B, Bauer M.
    Depress Anxiety; 2003 Nov; 17(1):43-8. PubMed ID: 12577277
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M, Bschor T, Bauer M, Lucka C, Lewitzka U, Ising M, Uhr M, Mueller-Oerlinghausen B, Baethge C.
    Neuropsychobiology; 2009 Nov; 60(1):23-30. PubMed ID: 19684420
    [Abstract] [Full Text] [Related]

  • 4. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.
    Bauer M, Adli M, Bschor T, Pilhatsch M, Pfennig A, Sasse J, Schmid R, Lewitzka U.
    Neuropsychobiology; 2010 Nov; 62(1):36-42. PubMed ID: 20453533
    [Abstract] [Full Text] [Related]

  • 5. Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients.
    Watson S, Gallagher P, Smith MS, Young AH, Ferrier IN.
    Psychoneuroendocrinology; 2007 Jun; 32(5):464-9. PubMed ID: 17442500
    [Abstract] [Full Text] [Related]

  • 6. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 7. Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
    Bauer M, Adli M, Baethge C, Berghöfer A, Sasse J, Heinz A, Bschor T.
    Can J Psychiatry; 2003 Aug; 48(7):440-8. PubMed ID: 12971013
    [Abstract] [Full Text] [Related]

  • 8. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression.
    Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M.
    Neuropsychopharmacology; 2002 Sep; 27(3):470-8. PubMed ID: 12225704
    [Abstract] [Full Text] [Related]

  • 9. Treatment of depression in bipolar disorder: new directions for research.
    Zornberg GL, Pope HG.
    J Clin Psychopharmacol; 1993 Dec; 13(6):397-408. PubMed ID: 8120153
    [Abstract] [Full Text] [Related]

  • 10. [Lithium in the treatment of acute depression].
    Adli M, Bschor T, Canata B, Döpfmer S, Bauer M.
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10):435-41. PubMed ID: 9825248
    [Abstract] [Full Text] [Related]

  • 11. Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression.
    Fawcett JA.
    J Clin Psychiatry; 2003 Oct; 64 Suppl 5():32-7. PubMed ID: 12720482
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and mechanisms of action of lithium augmentation in refractory major depression.
    Bschor T, Bauer M.
    Curr Pharm Des; 2006 Oct; 12(23):2985-92. PubMed ID: 16918427
    [Abstract] [Full Text] [Related]

  • 13. The use of lithium to augment antidepressant medication.
    Rouillon F, Gorwood P.
    J Clin Psychiatry; 1998 Oct; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
    [Abstract] [Full Text] [Related]

  • 14. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 15. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C.
    J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
    [Abstract] [Full Text] [Related]

  • 16. [Combination therapies in antidepressive drug refractory depression--an overview].
    Schmauss M, Erfurth A.
    Fortschr Neurol Psychiatr; 1996 Oct; 64(10):390-402. PubMed ID: 9036099
    [Abstract] [Full Text] [Related]

  • 17. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 18. The dexamethasone suppression test and response to somatic treatment: a review.
    Gitlin MJ, Gerner RH.
    J Clin Psychiatry; 1986 Jan; 47(1):16-21. PubMed ID: 3510195
    [Abstract] [Full Text] [Related]

  • 19. Augmentation strategies for treatment-resistant depression.
    Carvalho AF, Machado JR, Cavalcante JL.
    Curr Opin Psychiatry; 2009 Jan; 22(1):7-12. PubMed ID: 19122528
    [Abstract] [Full Text] [Related]

  • 20. Lithium augmentation therapy in refractory depression-update 2002.
    Bauer M, Forsthoff A, Baethge C, Adli M, Berghöfer A, Döpfmer S, Bschor T.
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):132-9. PubMed ID: 12904977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.